2 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
Follow Filariasis: new trials by email Literature Review of Filariasis trials Research Report on Filariasis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Assess Adverse Events, Change in Disease Activity and How Oral ABBV-4083 Capsules When Given Alone or In Combination With Albendazole Capsules Moves in The Body of Adult Participants With Onchocerca Volvulus Infection ABBV-4083, Placebo for ABBV-4083, Albendazole - Onchocerciasis | Phase 2 | Terminated | AbbVie | 153 | 2021-05-22 | 2024-09-19 |
| Efficacy and Microfilaricidal Kinetics of Imatinib for the Treatment of Loa Loa Imatinib Mesylate, Placebo - Loiasis | Phase 2 | Terminated | National Institute of Allergy and Infectious Diseases (NIAID) | 20 | 2019-09-16 | 2022-06-07 |
Loiasis (1) · Onchocerciasis (1) · Onchocerciasis, Ocular (1)
Helminthiasis (2) · Infections (2) · Nematode Infections (2) · Parasitic Diseases (2) · Secernentea Infections (2) · Spirurida Infections (2) · Eye Diseases (1) · Eye Infections (1) · Eye Infections, Parasitic (1) · Skin Diseases (1) · Skin Diseases, Infectious (1) · Skin Diseases, Parasitic (1) · Skin and Connective Tissue Diseases (1) · Vector Borne Diseases (1)
Albendazole (1) · Imatinib Mesylate (1)
AbbVie (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
Cameroon (1) · Democratic Republic of the Congo (1)